These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 17899624

  • 1. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL.
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [Abstract] [Full Text] [Related]

  • 2. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [Abstract] [Full Text] [Related]

  • 3. Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
    Kravitz MS, Pitashny M, Shoenfeld Y.
    J Clin Immunol; 2005 Nov; 25(6):582-91. PubMed ID: 16380821
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA, Trouw LA, van der Hoorn JW, Fallaux-van den Houten FC, Huizinga TW, Daha MR, Roos A.
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [Abstract] [Full Text] [Related]

  • 5. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C, Wetterö J.
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [Abstract] [Full Text] [Related]

  • 6. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 Jun; 33(6):1533-9. PubMed ID: 23255139
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to mannose binding lectin in patients with systemic lupus erythematosus.
    Mok MY, Jack DL, Lau CS, Fong DY, Turner MW, Isenberg DA, Lydyard PM.
    Lupus; 2004 Jun; 13(7):522-8. PubMed ID: 15352424
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 9. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 10. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI, Mohd Ashari NS, Mohd Daud K, Che Husin CM.
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [Abstract] [Full Text] [Related]

  • 11. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U.
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [Abstract] [Full Text] [Related]

  • 12. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 13. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus.
    Takahashi R, Tsutsumi A, Ohtani K, Goto D, Matsumoto I, Ito S, Wakamiya N, Sumida T.
    Clin Exp Immunol; 2004 Jun; 136(3):585-90. PubMed ID: 15147364
    [Abstract] [Full Text] [Related]

  • 14. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C, Bengtsson AA, Sturfelt G, Skogh T.
    Arthritis Res Ther; 2004 Jul; 6(2):R87-94. PubMed ID: 15059271
    [Abstract] [Full Text] [Related]

  • 16. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S, Vanhecke D, Trendelenburg M.
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M.
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.